Madison Cell and Gene Therapy Expansion Video

The science behind the development of gene- and cell-based therapies is as granular as it gets. Research at this level of precision requires the latest technology, state-of-the-art facilities and expert staff to produce optimal outcomes. In order to schedule more of your cell and gene studies and help you create more therapies to help patients, we have invested an estimated $9.2 million into a comprehensive nonclinical expansion of our Madison, Wisconsin site set to be ready for your studies by the end of the year. This complements other companywide investments dedicated to cell and gene therapy capabilities and support.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/videos/Madison-CGT-Expansion-VIDED010.png